About this trial
This study evaluates whether a 9-week healing interval is sufficient for subepithelial connective tissue graft (SCTG) maturation after palatal harvesting, and whether topical application of a polynucleotide and hyaluronic acid gel (Regenfast®) improves tissue quality. This is a randomized, blinded, controlled clinical trial with a split-mouth design involving 15 participants. Each participant undergoes bilateral SCTG harvesting from the palate in two surgical sessions 9 weeks apart. In the first session, one randomized side receives a single topical application of Regenfast® after graft removal; the contralateral side serves as control. Standardized tissue fragments (3×3 mm, 1.5 mm thickness) are collected from each graft for histological (HE, Picrosirius Red) and immunohistochemical analyses. Comparisons are made between grafts collected at baseline and after 9 weeks, and between sides treated with or without the gel.
Eligibility criteria
Qualifiers
Age between 18 and 60 years
Good general systemic health
Presence of multiple bilateral gingival recessions with indication for root coverage
Disqualifiers
Smoking of any intensity
Pregnancy or lactation
Oral lesions or alterations in the palatal mucosa
Previous history of graft harvesting from the donor area
Trial design
Treatments tested in this trial
- polynucleotide and hyaluronic acid gel
- subepithelial connective tissue graft harvesting
Treatment groups
Locations
Sponsors and collaborators
University of Sao Paulo
Lead sponsor
Instituto Kahn Odontologia
Collaborator